Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1930
https://www.valueinhealthjournal.com/article/S1098-3015(17)32264-7/fulltext
Title :
Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32264-7&doi=10.1016/j.jval.2017.08.1930
First page :
A720
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1757